Deciphera Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Deciphera Pharmaceuticals, Inc.

Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United…

Drug Manufacturers - Specialty & Generic
US, Waltham [HQ]
Supply · Problems · Premarket · Compliance

Supply Analysis

End of DCPH's Analysis
CIK: 1654151 CUSIP: 24344T101 ISIN: US24344T1016 LEI: - UEI: -
Secondary Listings
DCPH has no secondary listings inside our databases.